These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2240754)

  • 21. Double-blind, dose-response study of metaproterenol inhalant solution in children with acute asthma.
    Shapiro GG; Furukawa CT; Pierson WE; Chapko MK; Sharpe M; Bierman CW
    J Allergy Clin Immunol; 1987 Feb; 79(2):378-86. PubMed ID: 3546466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized comparison of atropine and metaproterenol inhalational therapies for refractory status asthmaticus.
    Young GP; Freitas P
    Ann Emerg Med; 1991 May; 20(5):513-9. PubMed ID: 2024791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD.
    LeDoux EJ; Morris JF; Temple WP; Duncan C
    Chest; 1989 May; 95(5):1013-6. PubMed ID: 2523291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchodilator and side effects of different modes of administration of metaproterenol: inhaled, oral, and in combination.
    Maguire GP; Emirgil C
    Am J Med Sci; 1986 Mar; 291(3):168-74. PubMed ID: 3513564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of inhaled metaproterenol, inhaled atropine sulfate, and their combination in treatment of children with acute asthma.
    Guill MF; Maloney MJ; DuRant RH
    Ann Allergy; 1987 Nov; 59(5):367-71. PubMed ID: 3318574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of inhaled atropine or metaproterenol in patients with chronic airway obstruction and therapeutic serum theophylline levels.
    Passamonte PM; Martinez AJ
    Chest; 1984 May; 85(5):610-5. PubMed ID: 6370619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy and safety of nebulized metaproterenol solution in bronchial asthma.
    Swarts CL; Hyde JS
    Chest; 1976 Nov; 70(5):617-20. PubMed ID: 975978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction.
    Turner JR; Corkery KJ; Eckman D; Gelb AM; Lipavsky A; Sheppard D
    Chest; 1988 Mar; 93(3):476-81. PubMed ID: 3342656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a multicenter study of nebulized inhalant bronchodilator solutions.
    Tashkin DP; Bleecker E; Braun S; Campbell S; DeGraff AC; Hudgel DW; Boyars MC; Sahn S
    Am J Med; 1996 Jan; 100(1A):62S-69. PubMed ID: 8610720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD.
    Karpel JP; Pesin J; Greenberg D; Gentry E
    Chest; 1990 Oct; 98(4):835-9. PubMed ID: 2145136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled metaproterenol is superior to inhaled cromolyn in protecting against cold-air-induced bronchospasm.
    Israel RH; Kohan JM; Poe RH; Kallay MC; Greenblatt DW; Rathbun S
    Respiration; 1988; 53(4):225-31. PubMed ID: 3140327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of an inhaled bronchodilator on gas distribution and over-all ventilatory efficiency in patients with chronic obstructive pulmonary disease.
    Cutillo A; Perondi R; Turiel M; Monti S
    Am J Med; 1976 Jul; 61(1):74-84. PubMed ID: 937373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.
    Tashkin DP; Ashutosh K; Bleecker ER; Britt EJ; Cugell DW; Cummiskey JM; DeLorenzo L; Gilman MJ; Gross GN; Gross NJ
    Am J Med; 1986 Nov; 81(5A):81-90. PubMed ID: 2947465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of metaproterenol on pulmonary mechanics, oxygenation, and ventilation in infants with chronic lung disease.
    Cabal LA; Larrazabal C; Ramanathan R; Durand M; Lewis D; Siassi B; Hodgman J
    J Pediatr; 1987 Jan; 110(1):116-9. PubMed ID: 3794869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol.
    Tinkelman DG; Brandon ML; Grieco M; Hudson L; Rosenthal RR; Spector SL; Tashkin D; Votteri B
    Ann Allergy; 1990 Feb; 64(2 Pt 2):202-6. PubMed ID: 2405746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term metaproterenol therapy in asthmatic children.
    Brandon ML
    JAMA; 1976 Feb; 235(7):736-7. PubMed ID: 765528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD.
    Karpel JP
    Chest; 1991 Apr; 99(4):871-6. PubMed ID: 1672634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen desaturation in adults following inhaled metaproterenol therapy.
    Hedges JR; Cionni DJ; Amsterdam JT; Embry S
    J Emerg Med; 1987; 5(2):77-81. PubMed ID: 3584922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Objective and subjective tremor responses to oral beta 2 agents on first exposure. A comparison of metaproterenol and terbutaline.
    Jenne JW; Ridley DJ; Marcucci RA; Druz WS; Rook JC
    Am Rev Respir Dis; 1982 Oct; 126(4):607-10. PubMed ID: 6751176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF.
    Weintraub SJ; Eschenbacher WL
    Chest; 1989 Apr; 95(4):861-4. PubMed ID: 2522385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.